Wormwood (Artemisia absinthium)
Also known as: Artemisia absinthium · Absinthe herb · Wermut
A traditional digestive bitter that showed striking results in two Crohn’s studies, including measurable reductions in TNF-α.
Early clinical research. Two controlled studies in Crohn’s disease, both with strongly positive results. Larger confirmatory trials have not yet been funded.
Affiliate disclosure: We may earn a commission on recommended products, at no extra cost to you. Learn more
How it works
Artemisia absinthium is rich in sesquiterpene lactones (notably absinthin and artabsin) and flavonoids that help modulate NF-κB activation and the release of TNF-α from immune cells. What makes wormwood remarkable is that researchers measured this directly in people: the Krebs trial tracked serum TNF-α and found it fell substantially in the wormwood group. Its intensely bitter compounds also stimulate digestive secretions, supporting appetite and digestion — the reason it has been prized as a digestive herb for centuries.
Traditional use
One of Europe’s oldest medicinal herbs, used since antiquity as a digestive bitter and to expel intestinal parasites. Germany’s Commission E recognised wormwood for loss of appetite and digestive complaints, and it remains a staple of European herbal practice.
Highlights
- In a double-blind, placebo-controlled study, 65% of people taking wormwood reached near-complete symptom remission by week 10 — while tapering their steroids — versus none on placebo.
- A second trial found symptom remission in 8 of 10 people taking wormwood, with Crohn’s activity scores falling from about 275 to below 175.
- The only botanical where researchers directly measured a drop in serum TNF-α in Crohn’s patients.
- Both studies used wormwood alongside existing therapy, supporting its role as a complementary option.
- Dose and preparation matter: quality, standardised products are important because of the herb’s natural thujone content.
What the research shows
Every study below links to its original publication so you can read it yourself. Many natural compounds have only been studied in small trials. That isn’t a verdict on them; it reflects how little funding exists for compounds that can’t be patented.
| Study | Design & population | Outcome |
|---|---|---|
| Omer 2007 Positive result | Double-blind, placebo-controlled trial with protocol-driven steroid taper 40 patients · Crohn’s disease on stable therapy including corticosteroids | Steady improvement in Crohn’s symptoms in the wormwood arm despite steroid tapering; 65% reached near-complete symptom remission by week 10 versus none on placebo. |
| Krebs 2010 Positive result | Controlled clinical trial, 6 weeks, add-on to basic Crohn’s therapy 20 patients (10 treated, 10 control) · Active Crohn’s disease | CDAI fell from ~275 to below 175 with symptom remission in 8 of 10 treated patients versus 2 of 10 controls; serum TNF-α was markedly suppressed. |
Double-blind, placebo-controlled trial with protocol-driven steroid taper · 40 patients · Crohn’s disease on stable therapy including corticosteroids
Steady improvement in Crohn’s symptoms in the wormwood arm despite steroid tapering; 65% reached near-complete symptom remission by week 10 versus none on placebo.
Controlled clinical trial, 6 weeks, add-on to basic Crohn’s therapy · 20 patients (10 treated, 10 control) · Active Crohn’s disease
CDAI fell from ~275 to below 175 with symptom remission in 8 of 10 treated patients versus 2 of 10 controls; serum TNF-α was markedly suppressed.
Using it alongside conventional care
Wormwood draws a lot of interest from people researching natural alternatives to Humira and Remicade, because it is one of very few herbs shown to lower TNF-α — the same inflammatory messenger those biologics target — in actual Crohn’s patients. The Omer 2007 study is especially notable for people hoping to reduce reliance on Prednisone: participants tapered their steroids under medical supervision while their symptoms continued to improve. Both studies were small, and wormwood was always added to existing care, so the right starting point is a conversation with your gastroenterologist about using it as a complementary layer and, where appropriate, a supervised steroid taper.
Medications mentioned
Humira (adalimumab)
Anti-TNF biologic
Neutralises tumour necrosis factor alpha (TNF-α), a master cytokine driving intestinal inflammation.
Remicade (infliximab)
Anti-TNF biologic
Chimeric monoclonal antibody against TNF-α, delivered by infusion.
Prednisone (prednisone / prednisolone)
Corticosteroid
Broad transcriptional suppression of inflammatory gene programmes.
Never stop or change a prescribed medication without your gastroenterologist. Many people use natural support alongside conventional care, and your care team can help you do that safely.
Recommended sourcing
Where to buyWhat to look for in Wormwood
- Artemisia absinthium specifically (not Artemisia annua or sweet wormwood)
- Dried powdered herb in capsules — the form used in the studies
- Thujone-controlled or tested products from reputable herbal manufacturers
- Clear per-capsule dose so you can match the studied amount
The studies used 750 mg of dried powdered herb three times daily. Wormwood is not for use during pregnancy.
Shop trusted retailers
Paid links: we may earn a commission when you buy through these links, at no extra cost to you. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Amounts used in research
Both trials used 750 mg of dried powdered herb three times daily (2,250 mg/day) for 6–10 weeks, as an addition to existing therapy.
Good to know
- Thujone is neurotoxic at high exposure and has been associated with seizures — dose and standardisation matter more here than for most herbs.
- Contraindicated in pregnancy and breastfeeding; historically used as an abortifacient.
- Avoid entirely if you have a seizure disorder or take medications that lower seizure threshold.
- Asteraceae family — cross-reactivity with ragweed, chrysanthemum and marigold allergy.
- The trials tapered steroids under physician supervision; stopping corticosteroids independently risks adrenal insufficiency and flare.
Community experiences
Reported benefit
Typical dose
Time to notice
Common pairings
Real-world data for Wormwood is coming. When our Community Symptom Tracker launches, this section will show anonymised, aggregated experiences from people with Crohn’s who have tried Wormwood: how many noticed a difference, what they took, and what they paired it with.
Community data will always be labelled as self-reported, and it won’t replace the published research above.
Coming soon
Tried Wormwood? Your experience matters.
Our Community Symptom Tracker will let you log what you take and how you feel — and see what’s working for people like you. Alongside it, our wellness store will offer curated, third-party-tested protocols.
Sources
-
Omer B, Krebs S, Omer H, Noor TO. · Phytomedicine · 2007 · PMID 17240130
-
Krebs S, Omer TN, Omer B. · Phytomedicine · 2010 · PMID 19962291
Phase 2 — in development
Where traditional research stops, our community begins
Natural compounds can’t be patented, so they rarely get the multi-million-dollar trials that drugs receive. That leaves people with Crohn’s without answers to the questions that matter most: what actually helps, at what dose, and for whom? Our Community Symptom Tracker will crowdsource those answers from real people living with Crohn’s, and our upcoming wellness store will make it easy to find quality, third-party-tested products.
- Log your symptoms, supplements and doses in a private daily tracker
- See what’s working for people with the same disease location and medications
- Contribute to the largest real-world dataset on natural Crohn’s support
- Shop curated, third-party-tested protocols from our upcoming store
Be one of the first to join
Early access is opening soon. Bookmark this page and check back — we’ll announce sign-ups here first.